WELL: Depression Prevention in Older Spousally-bereaved Adults

Sponsor
University of Pittsburgh (Other)
Overall Status
Recruiting
CT.gov ID
NCT04016896
Collaborator
National Institute of Mental Health (NIMH) (NIH)
250
1
2
44.4
5.6

Study Details

Study Description

Brief Summary

Using an indicated prevention approach, investigators propose to enroll 150 spousally-bereaved adults aged 60 years and older in the first 6 months after spousal death who are at high risk for major depression disorder because of subthreshold symptoms of depression. A confirmatory efficacy trial will be conducted in which participants will be randomly assigned to (a) self-monitor sleep, meals, and physical activity for 12 weeks using digital monitoring plus motivational health coaching (WELL; n=75); or (b) enhanced usual care (EUC, usual care plus study assessments, n=75). Objective actigraphic measures of the 24-hour pattern of day and nighttime activity - known as the rest-activity rhythm - will be measured to evaluate circadian rhythms as a mediator of treatment outcomes. Participants will be assessed at baseline, months 1 & 2, post-intervention, and 3, 6,12, 18-months post-intervention. In addition, the investigators will include a subset of participants bereaved by COVID-19 (or suspected as bereaved by COVID-19). Participants in this subset will undergo the same research procedures as the main cohort. Participants in both the main cohort and subset determined to be fully eligible will be randomized into two groups with a total of: usual care (EUC;n=125) and WELL (WELL; n=125).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: WIdowed Elders' LIfestyle after Loss (WELL)
  • Other: Enhanced Usual Care
N/A

Detailed Description

The primary aim of this R01 application is to test the efficacy of a new behavioral intervention that targets the timing and regularity of sleep, meals, and physical activity to stabilize circadian rhythms, for reducing symptoms of depression during the spousal bereavement period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Efficacy of a Healthy Lifestyle Intervention to Reduce Depression in Older Spousally-bereaved Adults
Actual Study Start Date :
Oct 20, 2020
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Widowed Elders' Lifestyle after Loss (WELL)

digital monitoring of sleep, meals, physical activity; motivational health coaching; personalized feedback

Behavioral: WIdowed Elders' LIfestyle after Loss (WELL)
Digital monitoring; motivational health coaching; personalized feedback

Active Comparator: Enhanced Usual Care

enhanced usual care

Other: Enhanced Usual Care
psychoeducation plus study assessments controlling for time and attention

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in depression symptom burden at 3 months [baseline vs. 3 months]

    Depression symptom burden as measured by the clinician administered Hamilton Rating Scale for Depression

Secondary Outcome Measures

  1. Change from baseline in the rest-activity rhythm at 3 months [baseline vs. 3 months]

    Rest-activity rhythm as measured by objective actigraphic technology

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged 60 years and older;

  • spousally (or partner) bereaved up to 12 months (includes bereaved as a result of COVID-19);

  • at-risk for major depressive disorder (MDD), based on high-risk markers defined as subthreshold symptoms of depression (Hamilton Depression Rating Scale score of >/= 9), together with absence of current MDD, post-traumatic stress disorder, or persistent complex bereavement disorder

Exclusion Criteria:
  • current Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-5) criteria for syndromal mood, psychosis within the last 12 months;

  • dementia/cognitive impairment; Telephone Interview Cognitive Screening (TICS) <19;

  • acute suicide risk; based on Herbeck et al. protocol for suicide risk management;

  • patients taking new psychotropic medications after spousal death to stabilize depression including antidepressants and benzodiazepines >4 days/week for more than two months. Individuals who have been on a stable dose for at least 1 month and agree not to change during participation, unless it is medically necessary, will be included.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPMC: WPIC- Bellefield Towers Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • University of Pittsburgh
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: sarah t stahl, PhD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sarah T. Stahl, PhD, Assistant Professor of Psychiatry, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04016896
Other Study ID Numbers:
  • STUDY19080030
  • R01MH118270
First Posted:
Jul 12, 2019
Last Update Posted:
Feb 4, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 4, 2022